Analytes/procedures in bold
type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Additional Information/Minimum Requirements
- This program is intended for laboratories using next-generation sequencing to determine tumor mutational burden.
- This program is appropriate for laboratories using targeted panels and whole exome sequencing.
Paired normal tissue is included.
- Paired normal tissue is included.
- Samples are 50% tumor.
- One 10‐µL gDNA (50ng/µL) specimen
- One 10‐µL gDNA (50ng/µL) paired normal tissue
- Shipment A: May 24
- Shipment B: November 29